|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 409 12th Street, SW |
Address2 |
|
City | Washington |
State | DC |
Zip Code | 20024 |
Country | USA |
3. Principal place of business (if different than line 2)
City | Washington |
State | DC |
Zip Code | 20024 |
Country | USA |
|
5. Senate ID# 400578740-12
|
||||||||
|
6. House ID# 412490000
|
TYPE OF REPORT | 8. Year | 2023 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Kira Peterson |
Date | 1/18/2024 3:40:16 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Abortion access (general); Access to Mifepristone (general); Contraception (general); Maternal Mortality and Morbidity (general); H.R. 1117, Advancing Safe Medications for Moms and Babies Act; obstetric and gynecologic care in rural and underserved areas (general); H.R. 3305/S. 1606, Black Maternal Health Momnibus Act; H.R. 1202/S. 704, Resident Education Deferred Interest (REDI) Act; H.R. 2389/S. 1302, Resident Physician Shortage Reduction Act of 2023; H.R. 2569, Doctors of Community (DOC) Act; Teaching Health Center Graduate Medication Education (general); H.R. 3838/S. 2415, Preventing Maternal Deaths Reauthorization Act of 2023; H.R. 3226/S. 1573, PREEMIE Reauthorization Act of 2023; inclusion of pregnant and lactating individuals in research (general); telemedicine (general); H.R. 5012/S. 2647, SHINE for Autumn Act; Rural Residency Planning and Development (RRPD) Program; H.R. 4581/S. 2231, Maternal and Child Health Stillbirth Prevention Act; Health Insurance Portability and Accountability Act (general); patient-physician relationship (general); Cost-sharing for maternity care (general); menopause research (general); Alliance for Innovation on Maternal Health; Residency programs in obstetrics and gynecology (general); Abortion training in obstetrics and gynecology residency programs (general); Obstetrician-gynecologist workforce (general); H.R. 5568/S. 2846, CARE for Moms Act; H.R. 5909, Caring for Grieving Families Act of 2023; S. 3509, Healthy MOM Act; H.R. 6746, Iron Deficiency Education and Awareness Act; H.R. 6743, WARM Act; H.R. 6103/S. 3137, Support Through Loss Act; S. 3070, Youth Prevention and Recovery Authorization Act of 2023; reproductive health data privacy (general); Treatment of reproductive health information under the Stored Communications Act (general); Tax treatment of stillbirths (general); Substance use disorder during pregnancy (general); Physician burnout (general); Maternal mental health (general); Artificial intelligence in health care (general); Coverage for infertility (general); Restrictions on menthol cigarettes and flavored cigars (general); Obstetric unit closures (general); Doxycycline Post-Exposure Prophylaxis (general); White House Initiative on Womens Health Research (general); Plans of Safe Care (general); Section 504 nondiscrimination on the basis of disability (general)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), White House Office, Centers For Disease Control & Prevention (CDC), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), Office of Management & Budget (OMB)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Rebecca |
Lauer |
|
|
|
Erin |
Alston |
|
|
|
Taylor |
Platt |
|
|
|
Rachel |
Tetlow |
|
|
|
Lillie |
Heyman |
|
|
|
Lisa |
Satterfield |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
H.R. 2474, Strengthening Medicare for Patients and Providers Act; physician payment under Medicare (general); H.R. 6371, Provider Reimbursement Stability Act of 2023; H.R. 6683, Preserving Seniors' Access to Physicians Act; graduate medical education (general); Prior authorization in Medicare (general); Medicaid free choice of provider requirement; Implementation of P.L. 117-328, Consolidated Appropriations Act, including permanent option for postpartum Medicaid extension; Bonus payments under Medicare for care provided in Health Professional Shortage Areas (general); Physician reimbursements under Medicaid (general); Site-neutral Medicare reimbursements (general)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Rebecca |
Lauer |
|
|
|
Erin |
Alston |
|
|
|
Taylor |
Platt |
|
|
|
Rachel |
Tetlow |
|
|
|
Lillie |
Heyman |
|
|
|
Lisa |
Satterfield |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code DEF
16. Specific lobbying issues
H.R. 2670/S. 2226, FY2024 National Defense Authorization Act; H.R. 6357, Access to Reproductive Care for Servicemembers Act; S. 1527, Access to Contraception for Servicemembers and Dependents Act of 2023; Access to maternity care for servicemembers and dependents (general); Online resources for pregnant servicemembers and dependents (general); Pregnancy and pregnancy loss as qualifying life events under TRICARE (general).
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Rebecca |
Lauer |
|
|
|
Rachel |
Tetlow |
|
|
|
Lillie |
Heyman |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code VET
16. Specific lobbying issues
Abortion care at the Department of Veterans Affairs (general).
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Rebecca |
Lauer |
|
|
|
Rachel |
Tetlow |
|
|
|
Lillie |
Heyman |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code IMM
16. Specific lobbying issues
H.R. 4942/S. 665, Conrad State 30 and Physician Access Reauthorization; H.R. 3993/S. 2128, Stop Shackling and Detaining Pregnant Women Act
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, U.S. Citizenship & Immigration Services (USCIS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Rebecca |
Lauer |
|
|
|
Lillie |
Heyman |
|
|
|
Rachel |
Tetlow |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Alliance for Innovation on Maternal Health; Safe Motherhood and Infant Health Program; Centers for Disease Control and Prevention (general); CDC Office on Smoking and Health; National Institutes of Health (general); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Task Force on Research Specific to Pregnant Women and Lactating Women (PRGLAC); Teaching Health Center Graduate Medical Education Program; Congressionally Directed Medical Research Program; Defense Health Research Programs; Title X family planning program (general); Title V Maternal and Child Health Block Grant; Special Supplemental Nutrition Program for Women, Infants, and Children (WIC); Obstetrics and gynecology graduate medical education programs; Temporary Assistance for Needy Families; H.R. 5894/S. 2624, FY2024 Labor, Health and Human Services, and Education, and Related Agencies appropriations bill; H.R. 4368/S. 2131, FY2024 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies appropriations bill; H.R. 4665/S. 2438, FY2024 State, Foreign Operations, and Related Programs appropriations bill; H.R. 4365/S. 2587, FY2024 Defense appropriations bill; H.R. 4366/S. 2127, FY2024 Military Construction, Veterans Affairs, and Related Agencies appropriations bill.
17. House(s) of Congress and Federal agencies Check if None
Centers For Disease Control & Prevention (CDC), Natl Institutes of Health (NIH), U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Health Resources & Services Administration (HRSA), Health & Human Services - Dept of (HHS), Administration for Children & Families (ACF)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Rachel |
Tetlow |
|
|
|
Rebecca |
Lauer |
|
|
|
Lillie |
Heyman |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
Lobbyist Name | Description of Offense(s) |